Janney Montgomery Scott’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-21,688
Closed -$191K 2758
2024
Q2
$191K Sell
21,688
-119,223
-85% -$1.18M ﹤0.01% 2460
2024
Q1
$1.66M Sell
140,911
-22,648
-14% -$274K ﹤0.01% 1244
2023
Q4
$1.84M Sell
163,559
-93,328
-36% -$782K 0.01% 1141
2023
Q3
$1.74M Buy
256,887
+32,482
+14% +$269K 0.01% 1078
2023
Q2
$2.04M Sell
224,405
-15,043
-6% -$121K 0.01% 1054
2023
Q1
$1.55M Buy
239,448
+14,869
+7% +$120K 0.01% 1096
2022
Q4
$1.42M Buy
224,579
+29,093
+15% +$206K 0.01% 1184
2022
Q3
$1.21M Sell
195,486
-15,832
-7% -$139K 0.01% 1224
2022
Q2
$1.73M Sell
211,318
-49,392
-19% -$368K 0.01% 997
2022
Q1
$2.19M Buy
260,710
+146,796
+129% +$1.32M 0.01% 880
2021
Q4
$1.16M Buy
113,914
+14,591
+15% +$216K ﹤0.01% 1243
2021
Q3
$1.93M Buy
99,323
+41,983
+73% +$811K 0.01% 971
2021
Q2
$1.01M Buy
+57,340
New +$773K ﹤0.01% 1266

Other funds holding INMB

Janney Montgomery Scott's INMB Position: Q3 2024 in Review

Janney Montgomery Scott sold out of INmune Bio (INMB) in Q3 2024, closing a stake of 21,688 shares — an estimated $191K sold.

Janney Montgomery Scott first reported a position in INMB in Q2 2021 and held it in 13 quarters. The position peaked at $2.19M in Q1 2022. 67 funds tracked by Wall St. Rank hold INMB as of Q3 2024.

  • Janney Montgomery Scott reported no remaining INmune Bio position as of Q3 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 21,688 INmune Bio shares in Q3 2024, an estimated $191K.
  • Janney Montgomery Scott first reported a position in INmune Bio in Q2 2021 and held it in 13 quarters.
  • Janney Montgomery Scott's INmune Bio position peaked at $2.19M in Q1 2022.
  • 67 funds tracked by Wall St. Rank held INmune Bio as of Q3 2024.

Based on Janney Montgomery Scott's 13F filing for Q3 2024, filed 29 Oct 2024.